PVParth Nalin Vakil

Parth Nalin Vakil

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Parth Nalin Vakil has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Selective Uptake Into Drug Resistant Mammalian Cancer by Cell Penetrating Peptide-Mediated Delivery

    by Kate J. F. Carnevale, Megan E. Muroski, Parth Nalin Vakil, Megan E. Foley, Geoffry Laufersky, Rachael Kenworthy, Diego A. R. Zorio, Thomas J. Morgan, Cathy W. Levenson, Geoffrey F. Strouse

    Research over the past decade has identified several of the key limiting features in multidrug resistance (MDR) cancer ther-apy applications, such as evolving glycoprotein receptors at the surface of the cell that limit therapeutic uptake, metabolic changes leading to protection from multidrug resistant mediators by enhanced degradation or efflux of therapeutics, and difficulty ensuring retention of intact and functional drugs once endocytosed. Nanoparticles have been demonstrated to be effective delivery vehicles for a plethora of therapeutic agents and, in the case of nucleic acid-based agents, they provide protective advantages. Functionalizing cell penetrating peptides (CPPs), also known as protein transduction domains, onto the surface of a fluorescent quantum dots creates a labelled delivery package to investigate the nuances and difficulties of drug transport in MDR cancer cells for potential future clinical applications of diverse nanoparticle therapeutic delivery strategies. In this study, eight distinct cell penetrating peptides were used (CAAKA, VP-22, HIV-TAT, Ku-70, and hCT(9-32), integrin-β3, HIV-gp41, and K-FGF) to examine the different cellular uptake profiles in cancer versus drug resistant melano-ma (A375 & A375-R), mesothelioma (MSTO & MSTO-R), and glioma (rat 9L & 9L-R, and human U87 & LN18), cell lines. The results of this study demonstrate that cell penetrating peptide uptake varies with the amount of drug resistance and cell type, likely due to changes in cell surface markers. This study provides insight to developing functional nanoplatform deliv-ery systems in drug resistant cancer models.


  • Microwave Enhancement of Autocatalytic Growth of Nanometals

    by Bridgett Ashley, Parth N. Vakil, Brian B. Lynch, Christopher M. Dyer, Joseph B. Tracy, Jeffery Owens, Geoffrey F. Strouse

    The desire for designing efficient synthetic methods that lead to industrially important nanomaterials has led a desire to more fully understand the mechanism of growth and how modern synthetic techniques can be employed. Microwave (MW) synthesis is one such technique that has attracted attention as a green, sustainable method. The reports of enhancement of formation rates and improved quality for MW driven reactions are intriguing, but the lack of understanding of the reaction mechanism and how coupling to the MW field leads to these observations is concerning. In this manuscript, the growth of a metal nanoparticles (NP) in a microwave cavity is spectroscopically analyzed, and compared with the classical autocatalytic method of NP growth to elucidate the underpinnings for the observed enhanced growth behavior for metal NPs prepared in a MW field. The study illustrates that microwave synthesis of nickel and gold nanoparticles below saturation conditions follows the Finke–Watzky mechanism of nucleation and growth. The enhancement of the reaction arises from the size dependent increase in MW absorption cross section for the metal NPs. For Ni, the presence of oxides is considered via theoretical computations and compared to dielectric measurements of isolated nickel NPs. The study definitively shows that MW growth can be modeled by an autocatalytic mechanism that directly leads to the observed enhanced rates and improved quality widely reported in the nanomaterial community when MW irradiation is employed.